Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5284398
Max Phase: Preclinical
Molecular Formula: C38H59N5O13
Molecular Weight: 793.91
Associated Items:
ID: ALA5284398
Max Phase: Preclinical
Molecular Formula: C38H59N5O13
Molecular Weight: 793.91
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCC(=O)O[C@@H]1[C@H](OC)[C@@H]([C@@H](O[C@@H]2OC(C(=O)N[C@H]3CCC[C@@H](C)NC3=O)=C[C@@H](O)[C@H]2O)C(N)=O)O[C@H]1n1ccc(=O)[nH]c1=O
Standard InChI: InChI=1S/C38H59N5O13/c1-4-5-6-7-8-9-10-11-12-13-14-18-27(46)54-32-29(52-3)30(55-36(32)43-20-19-26(45)42-38(43)51)31(33(39)48)56-37-28(47)24(44)21-25(53-37)35(50)41-23-17-15-16-22(2)40-34(23)49/h19-24,28-32,36-37,44,47H,4-18H2,1-3H3,(H2,39,48)(H,40,49)(H,41,50)(H,42,45,51)/t22-,23+,24-,28-,29-,30+,31-,32-,36-,37+/m1/s1
Standard InChI Key: VRWMWOCVTFGXIW-XLKIMWGESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 793.91 | Molecular Weight (Monoisotopic): 793.4109 | AlogP: 1.07 | #Rotatable Bonds: 21 |
Polar Surface Area: 259.83 | Molecular Species: NEUTRAL | HBA: 14 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.70 | CX Basic pKa: | CX LogP: 2.22 | CX LogD: 2.22 |
Aromatic Rings: 1 | Heavy Atoms: 56 | QED Weighted: 0.08 | Np Likeness Score: 0.88 |
1. Serpi M, Ferrari V, Pertusati F.. (2016) Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?, 59 (23): [PMID:27607900] [10.1021/acs.jmedchem.6b00325] |
Source(1):